947 related articles for article (PubMed ID: 19012492)
21. Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine.
Ferrier-Rembert A; Drillien R; Tournier JN; Garin D; Crance JM
Vaccine; 2008 Mar; 26(14):1794-804. PubMed ID: 18336966
[TBL] [Abstract][Full Text] [Related]
22. Genomic sequence of a clonal isolate of the vaccinia virus Lister strain employed for smallpox vaccination in France and its comparison to other orthopoxviruses.
Garcel A; Crance JM; Drillien R; Garin D; Favier AL
J Gen Virol; 2007 Jul; 88(Pt 7):1906-1916. PubMed ID: 17554021
[TBL] [Abstract][Full Text] [Related]
23. Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host.
Fang M; Cheng H; Dai Z; Bu Z; Sigal LJ
Virology; 2006 Feb; 345(1):231-43. PubMed ID: 16256161
[TBL] [Abstract][Full Text] [Related]
24. Tail scarification with Vaccinia virus Lister as a model for evaluation of smallpox vaccine potency in mice.
Melamed S; Paran N; Katz L; Ben-Nathan D; Israely T; Schneider P; Levin R; Lustig S
Vaccine; 2007 Nov; 25(45):7743-53. PubMed ID: 17928110
[TBL] [Abstract][Full Text] [Related]
25. Capturing the natural diversity of the human antibody response against vaccinia virus.
Lantto J; Haahr Hansen M; Rasmussen SK; Steinaa L; Poulsen TR; Duggan J; Dennis M; Naylor I; Easterbrook L; Bregenholt S; Haurum J; Jensen A
J Virol; 2011 Feb; 85(4):1820-33. PubMed ID: 21147924
[TBL] [Abstract][Full Text] [Related]
26. Comparative efficacy of replicating smallpox vaccine strains in a murine challenge model.
Phelps A; Gates AJ; Hillier M; Eastaugh L; Ulaeto DO
Vaccine; 2005 May; 23(27):3500-7. PubMed ID: 15855008
[TBL] [Abstract][Full Text] [Related]
27. Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine.
Vollmar J; Arndtz N; Eckl KM; Thomsen T; Petzold B; Mateo L; Schlereth B; Handley A; King L; Hülsemann V; Tzatzaris M; Merkl K; Wulff N; Chaplin P
Vaccine; 2006 Mar; 24(12):2065-70. PubMed ID: 16337719
[TBL] [Abstract][Full Text] [Related]
28. Real time PCR for the assessment of CD8+ T cellular immune response after prophylactic vaccinia vaccination.
Trojan A; Rajeswaran R; Montemurro M; Mütsch M; Steffen R
J Clin Virol; 2007 Sep; 40(1):80-3. PubMed ID: 17644471
[TBL] [Abstract][Full Text] [Related]
29. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox.
Earl PL; Americo JL; Wyatt LS; Eller LA; Whitbeck JC; Cohen GH; Eisenberg RJ; Hartmann CJ; Jackson DL; Kulesh DA; Martinez MJ; Miller DM; Mucker EM; Shamblin JD; Zwiers SH; Huggins JW; Jahrling PB; Moss B
Nature; 2004 Mar; 428(6979):182-5. PubMed ID: 15014500
[TBL] [Abstract][Full Text] [Related]
30. Recombinant A27 protein synergizes with modified vaccinia Ankara in conferring protection against a lethal vaccinia virus challenge.
He Y; Meseda CA; Vassell RA; Merchlinsky M; Weir JP; Weiss CD
Vaccine; 2010 Jan; 28(3):699-706. PubMed ID: 19887133
[TBL] [Abstract][Full Text] [Related]
31. Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus.
Stittelaar KJ; van Amerongen G; Kondova I; Kuiken T; van Lavieren RF; Pistoor FH; Niesters HG; van Doornum G; van der Zeijst BA; Mateo L; Chaplin PJ; Osterhaus AD
J Virol; 2005 Jun; 79(12):7845-51. PubMed ID: 15919938
[TBL] [Abstract][Full Text] [Related]
32. Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox.
Kremer M; Suezer Y; Volz A; Frenz T; Majzoub M; Hanschmann KM; Lehmann MH; Kalinke U; Sutter G
PLoS Pathog; 2012; 8(3):e1002557. PubMed ID: 22396645
[TBL] [Abstract][Full Text] [Related]
33. Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.
Meseda CA; Weir JP
Future Microbiol; 2010 Sep; 5(9):1367-82. PubMed ID: 20860482
[TBL] [Abstract][Full Text] [Related]
34. Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge.
Empig C; Kenner JR; Perret-Gentil M; Youree BE; Bell E; Chen A; Gurwith M; Higgins K; Lock M; Rice AD; Schriewer J; Sinangil F; White E; Buller RM; Dermody TS; Isaacs SN; Moyer RW
Vaccine; 2006 Apr; 24(17):3686-94. PubMed ID: 16430997
[TBL] [Abstract][Full Text] [Related]
35. [Development of a numerically additive combined vaccine against tetanus and smallpox].
Mayr A; Baljer G; Wagner C; Sailer J
Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):206-18. PubMed ID: 2990123
[TBL] [Abstract][Full Text] [Related]
36. Genomic differences of Vaccinia virus clones from Dryvax smallpox vaccine: the Dryvax-like ACAM2000 and the mouse neurovirulent Clone-3.
Osborne JD; Da Silva M; Frace AM; Sammons SA; Olsen-Rasmussen M; Upton C; Buller RM; Chen N; Feng Z; Roper RL; Liu J; Pougatcheva S; Chen W; Wohlhueter RM; Esposito JJ
Vaccine; 2007 Dec; 25(52):8807-32. PubMed ID: 18037545
[TBL] [Abstract][Full Text] [Related]
37. An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection.
Morikawa S; Sakiyama T; Hasegawa H; Saijo M; Maeda A; Kurane I; Maeno G; Kimura J; Hirama C; Yoshida T; Asahi-Ozaki Y; Sata T; Kurata T; Kojima A
J Virol; 2005 Sep; 79(18):11873-91. PubMed ID: 16140764
[TBL] [Abstract][Full Text] [Related]
38. Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge.
Pulford DJ; Gates A; Bridge SH; Robinson JH; Ulaeto D
Vaccine; 2004 Sep; 22(25-26):3358-66. PubMed ID: 15308360
[TBL] [Abstract][Full Text] [Related]
39. Microarray assay for evaluation of the genetic stability of modified vaccinia virus Ankara B5R gene.
Laassri M; Meseda CA; Williams O; Merchlinsky M; Weir JP; Chumakov K
J Med Virol; 2007 Jun; 79(6):791-802. PubMed ID: 17457926
[TBL] [Abstract][Full Text] [Related]
40. Lung surfactant DPPG phospholipid inhibits vaccinia virus infection.
Perino J; Crouzier D; Spehner D; Debouzy JC; Garin D; Crance JM; Favier AL
Antiviral Res; 2011 Jan; 89(1):89-97. PubMed ID: 21095206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
